Acrivon Therapeutics, Inc. (ACRV) Net income 2021–2025
Acrivon Therapeutics, Inc. (ACRV) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$77.9MFY2025 · since FY2021: -$16.2M → -$77.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$77.9M | +3.3% |
| FY2024 | -$80.6M | -33.4% |
| FY2023 | -$60.4M | -93.8% |
| FY2022 | -$31.2M | -91.9% |
| FY2021 | -$16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice